Table 4.
Univariate analyses for IHS MO/MA and MDD with and without sex-limitation
| Disorders | Total sample | Sex-limitation | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Female | Male | ||||||||
|
| |||||||||
| A | C | E | A | C | E | A | C | E | |
| IHS MO/MA | 0.59 (0.43–0.76) | 0.25 (0.090–0.39) | 0.16 (0.12–0.21) | 0.65 (0.46–0.82) | 0.19 (0.044–0.36) | 0.16 (0.11–0.22) | 0.43 (0.083–0.75) | 0.32 (0.051–0.62) | 0.25 (0.15–0.39) |
| MDD | 0.49 (0.43–0.54) | – | 0.51 (0.46–0.57) | 0.51 (0.44–0.57) | – | 0.49 (0.43–0.56) | 0.46 (0.36–0.56) | – | 0.54 (0.44–0.64) |
A: additive genetic factors; C: non-unique environmental factors E: unique environmental factors.